3 min read

Experience the Difference with UBC’s REMS Professionals

When it comes to launching Risk Evaluation and Mitigation Strategies (REMS), experience matters.
At UBC, we are committed to our continued partnership with our customers and to providing exceptional work on behalf of our patients

At UBC, we have a tenured group of REMS professionals who have been successfully designing and launching REMS for well over a decade. In fact, the first REMS launched was designed and implemented by UBC.

Our customers have consistently expressed their appreciation for the exceptional work and support provided by our team. One customer noted the positive outcome of a recent REMS inspection, with no findings or observations, and credited UBC as being critical to its success. Even when faced with challenging projects, our customers consider themselves lucky to have worked with UBC. Our comprehensive, efficient approach has enabled audits to go smoothly, and our performance and management of programs continue to be stellar.

At UBC, we are committed to our continued partnership with our customers and to providing exceptional work on behalf of our patients. Experience the difference with UBC’s REMS professionals.

For more information on UBC’s comprehensive risk evaluation and mitigation strategies, get in touch with us HERE.

ABOUT UBC:  United BioSource LLC (UBC) is the leading provider of evidence development solutions with expertise in uniting evidence and access. UBC helps biopharma mitigate risk, address product hurdles, and demonstrate safety, efficacy, and value under real-world conditions. Our combined scientific expertise in risk evaluation and mitigation strategies, underpinned by innovative technologies, offer our customers flexible solutions generating the relevant insights necessary to make informed decisions earlier, meet stakeholder requirements, and ensure the safety of products. UBC leads the market in providing integrated, comprehensive clinical, safety, and commercialization services and is uniquely positioned to seamlessly integrate best-in-class services throughout the lifecycle of a product.

ABOUT THE AUTHOR:

Natalie O’Donnell, BSN, RN,  SVP, Head of Safety & Risk Management

Ms. O’Donnell’s has more than 20 years of healthcare and clinical research experience, with a focus in risk management for the last 12 years and serves as Senior Vice President and Head of Safety and Risk Management at UBC. She is responsible for UBC’s risk evaluation and mitigation strategy and pharmacovigilance services and plays a critical role in ensuring the safe and effective use of pharmaceutical products. Her career began as a registered nurse in the hospital setting where she was responsible for medical surgical patients and pediatric patients. She was also a certified oncology nurse. With a passion for patient-centric healthcare, she continues to drive excellence and ensure patient safety remains at the heart of UBC’s mission.

Other Recent Posts

Press
3 min read

UBC Appoints Anthony Luttenberger Chief Commercial Officer

Biopharma services industry veteran brings decades of experience spanning late-stage, clinical trials, & post-approval commercial support.
Press
1 min read

UBC Listed as a Citeline Awards Finalist for Excellence in RWE

UBC is once again a finalist for the Citeline Awards, with our 2024 nomination coming in the Excellence in RWE category.
Press
3 min read

UBC Recognized as a Citeline Awards Finalist Again

The Citeline Awards have recognized UBC & Seqster’s innovative collaboration as a shortlisted finalist for the Best Patient-Facing Technology Initiative Category in 2023.

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.